|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||
CLINICAL STUDY |
A Iranmanesh, Research & Development Office, VA Medical Center, Salem, United States
J Veldhuis, Endocrine Research Unit, Mayo Clinic, Rochester, 55905, United States
Correspondence: Johannes Veldhuis, Email: veldhuis.johannes{at}mayo.edu
Abstract
Background. ACTH secretion is under hypothalamic stimulatory (feedforward) and adrenal inhibitory (feedback) control.
Hypothesis. Assessment of overnight ACTH secretion during a hypocortisolemic clamp will permit estimation of changing feedforward and feedback.
Subjects. Seven healthy men.
Interventions. An oral dose of placebo, metyrapone (METY, 3 g) or ketoconazole (KTCZ, 1.2 g) was given at midnight (MN) to block glucocorticoid synthesis. Plasma ACTH was sampled every 10 min (MN to 0800 h).
Analysis. Variable-waveform deconvolution analysis of ACTH secretion, and approximate entropy (ApEn) analysis of pattern regularity.
Results. Compared with placebo, METY and KTCZ reduced morning cortisol concentrations by
77% and 54%, respectively [P < 0.001]. Hypocortisolemia elevated pulsatile ACTH secretion by 8.2-fold (METY) and 5.3-fold (KTCZ) [both P < 0.001]. Basal ACTH secretion rose by 3.4-fold under METY-induced cortisol depletion (P = 0.020). ACTH secretory-burst shape and half-life were stable. ApEn of ACTH release declined overnight (P = 0.021) and with drug (P = 0.001), denoting enhanced feedforward coordination.
Conclusion. The combined data predict overnight amplification and coordination of hypothalamic feedforward drive onto ACTH release. Therefore, disruption of either mechanism might contribute to clinical pathophysiology, such as late-day elevations of cortisol output in fasting, alcoholism, depression or aging.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |